Management of Persistent Erythrocytosis with New-Onset Leukocytosis
Diagnostic Workup and Immediate Management
- The American Society of Hematology recommends performing a complete blood count with differential to assess all three cell lines and examine for left shift or immature cells in patients with suspected polycythemia vera 1
- The National Comprehensive Cancer Network suggests obtaining peripheral blood smear to evaluate cell morphology, maturity, and rule out acute leukemia or other primary bone marrow disorders in patients with suspected polycythemia vera 1
- In patients with white blood cell count >100,000/μL, the American Society of Hematology recommends initiating aggressive intravenous hydration at 2.5-3 liters/m²/day to prevent tumor lysis syndrome and leukostasis complications 1, 2
- The National Comprehensive Cancer Network recommends starting hydroxyurea 50-60 mg/kg/day to achieve 50% WBC reduction within 1-2 weeks if hyperleukocytosis is present in patients with suspected polycythemia vera 1
- The American Society of Hematology suggests monitoring for leukostasis symptoms, which constitute a medical emergency requiring potential leukapheresis, in patients with hyperleukocytosis 2
Risk Stratification and Treatment
- The European LeukemiaNet recommends classifying patients into high-risk or low-risk categories based on age and history of thrombosis to determine treatment intensity in polycythemia vera 3
- The American College of Cardiology recommends avoiding repeated routine phlebotomies without monitoring iron status, as iron depletion decreases oxygen-carrying capacity and increases stroke risk in patients with polycythemia vera 4